BSD Medical Corporation | Return to Homepage
Home    |    Contact us    |    Terms of Use    |    Privacy Statement    |    Site Map        
BSD Medical -- Delivering Thermal Energy to Medicine
About BSD Medical Products For Patients For Healthcare Professionals Investor Relations

Press Releases

  • 3/3/15 10:17 am MST
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors is exploring strategic options to enhance shareholder value.  The Board has retained SunTrust Robinson Humphrey as its financial advisor to assist in this important initiative for the Company. “We have taken definitive steps over the past few months that have positioned the company for strong futuremore...
  • 2/26/15 9:15 am MST
    Perseon Corporation (NASDAQ: PRSN) (Perseon or the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Jennifer R. Hoglin as Vice President of Global Marketing, effective February 17, 2015. Ms. Hoglin is an executive marketing professional with 20 years of experience in product, brand, and business development experience in primarily life sciences as well as multiple other industries.Clint Carnell, CEO of Perseon,more...
  • 2/24/15 11:53 am MST

    Perseon to Showcase its Leading Microwave Ablation Technology at 40th Annual Scientific Meeting of Society of Interventional Radiology (SIR)

    BSD Medical Corporation (NASDAQ:BSDM) (the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today unveiled its new name and corporate identity, Perseon Corporation (Perseon).  The Company’s new name is coupled with a new visual identity, including the new tagline “Science for Humanity.”“The change of our name to Perseon, a word with multiple references to our mission and technology, succinctly represents our focus as a pure play microwave ablationmore...
  • 2/17/15 7:20 am MST

     

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the appointment of Ben Beckham as Vice President of North American Sales, effective February 16, 2015.  Mr. Beckham is an accomplished and performance-driven life sciences executive with over 20 years of experience in medical sales management and marketing. Clint Carnell, CEO of BSD Medical, commented, “Ben’s signature strengths aremore...
  • 2/9/15 2:06 pm MST
    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the resignation of Gerhard W. Sennewald, Ph.D., and Douglas P. Boyd, Ph.D., as members of the Board of Directors. Mr. Boyd’s resignation was effective on January 28, 2015 and Mr. Sennewald’s resignation was effective February 4, 2015.“With our changing product focus, we are seeking new independent directors with vast life science andmore...
  • 1/29/15 10:50 am MST
    • Submits non-binding term sheet for hyperthermia assets

    • Commences monetization of real estate assets

    • Expects 180-day grace period extension from NASDAQ

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today provided an update on its strategic plan for the Company first outlined on January 12, 2015.  As part of this plan, BSD intends to exit its hyperthermia product line this year and has submitted a non-binding term sheet for the potential sale of its assets.  Terms are still being negotiated; however, the Company expects to close the transactionmore...
  • 1/15/15 7:20 am MST

    Investor & Analyst Conference Call Today at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported financial results for the fiscal first quarter of 2015 ended November 30, 2014. Total revenues were $843,168 for the first quarter ended November 30, 2014, a decrease of 37% compared to total revenues of $1,330,645 for the three months ended November 30, 2013.  Product sales in the three months ended November 30, 2013 includedmore...
  • 1/12/15 7:21 am MST

    Investor & Analyst Conference Call Scheduled for Thursday, January 15 at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time; RSVP Required

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced its strategic plans and initial revenue targets for the upcoming three-year period. The announcement was made in advance of investor and analyst meetings BSD management is holding this week in the San Francisco Bay Area, concluding with an Investor & Analyst Update Call on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.mmore...
  • 12/29/14 8:31 am MST

    Live Conference Call and Webcast Scheduled for Thursday, January 15 at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time; RSVP Required

    Salt Lake City – December 29, 2014 – BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that BSD’s new CEO, Clint Carnell, will host an Investor & Analyst Update Call outlining BSD’s three year strategic vision on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time.Individuals interested in listening to the conference call may do so by visiting the Investormore...
  • 11/13/14 7:15 am MST
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its fiscal year ended August 31, 2014. Financial Highlights for Fiscal Year 2014 Total revenues of $5.3 million, a $1.6 million increase from $3.7 million for fiscal year 2013 Total stockholders’more...


Business Wire InvestorHQ℠